The functional experiments disclosed that miR‐185‐5p was reversely modulated by MALfaAT1 in NSCLC cells, implying MALAT1 might participate in NSCLC progression via miR‐185‐5p. Here, MALAT1 is linked to non-small cell lung carcinoma.